External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement

• David Hajage,

  Affiliation Department of Biostatistics, Institut Curie, Paris, France

  ⨯
• Yann de Rycke,

  Affiliation Department of Biostatistics, Institut Curie, Paris, France

  ⨯
• Marc Bollet,

  Affiliation Department of Radiotherapy, Institut Curie, Paris, France

  ⨯
• Alexia Savignoni,

  Affiliation Department of Biostatistics, Institut Curie, Paris, France

  ⨯
• Martial Caly,

  Affiliation Department of Tumour Biology, Institut Curie, Paris, France

  ⨯
• Jean-Yves Pierga,

  Affiliation Department of Medical Oncology, Institut Curie, Paris, France

  ⨯
• Hugo M. Horlings,

  Affiliation Department of Pathology, Academic Medical Center, Amsterdam, Netherlands

  ⨯
• Marc J. Van de Vijver,

  Affiliation Department of Pathology, Academic Medical Center, Amsterdam, Netherlands

  ⨯
• Anne Vincent-Salomon,

  Affiliation Department of Tumour Biology, Institut Curie, Paris, France

  ⨯
• Brigitte Sigal-Zafrani,

  Affiliation Department of Tumour Biology, Institut Curie, Paris, France

  ⨯
• Claire Senechal,

  Affiliation Department of Surgery, Institut Curie, Paris, France

  ⨯
• Bernard Asselain,

  Affiliation Department of Biostatistics, Institut Curie, Paris, France

  ⨯
• Xavier Sastre,

  Affiliation Department of Tumour Biology, Institut Curie, Paris, France

  ⨯
• Fabien Reyal

  * E-mail: Fabien.reyal@curie.net

  Affiliation Department of Surgery, Institut Curie, Paris, France

  ⨯